VADUZ, Liechtenstein, May 27, 2025 /PRNewswire/ -- Implantica AG (publ.) reports successful pre-launch activities in the U.S., pending FDA approval, with European real-world clinical evidence generating much interest from U.S. surgeons. Several presentations on RefuxStop™ were held at...
Read More Details
Finally We wish PressBee provided you with enough information of ( Implantica's RefluxStop™ stimulates intensive dialogue at DDW, the world's largest Digestive Disease conference, held in the U.S. )
Also on site :
- Jessica Hecht Reveals the Hardest Part of Being a Tony Nominee (Exclusive)
- '90s Bombshell, 53, Makes Bold Statement About 'Natural Aging'
- Julia Fox's Net Worth in 2025 Proves She's an It Girl